AG00ADO8

14362-31-3 | Chlorcyclizine hydrochloride 

Chemical structure of Chlorcyclizine hydrochloride , CAS 14362-31-3
AG00ADO8
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 14362-31-3
Catalog Number AG00ADO8(AGN-PC-0PUC6N)
Chemical Name Chlorcyclizine hydrochloride 
EC Number 238-335-1
IUPAC Name 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine;hydrochloride
InChI InChI=1S/C18H21ClN2.ClH/c1-20-11-13-21(14-12-20)18(15-5-3-2-4-6-15)16-7-9-17(19)10-8-16;/h2-10,18H,11-14H2,1H3;1H
InChI Key MSIJLVMSKDXAQN-UHFFFAOYSA-N
MDL Number MFCD00035329
Molecular Formula C18H22Cl2N2
Molecular Weight 337.2867
SMILES CN1CCN(C(C2=CC=C(Cl)C=C2)C3=CC=CC=C3)CC1.Cl
Synonyms
eramide, Azaron, Histantin, Pyribenzamine, Tripelennamine, Tripelennamine Citrate, Tripelennamine Citrate (1:1), Tripelennamine Hydrochloride, Tripelennamine Maleate, Tripelennamine Maleate (1:1), Tripelennamine Monohydrochloride, Vetibenzamin, CHLORCYCLIZINE HYDROCHLORIDE, CHLORCYCLIZINE HCl, Histantin, Eramide, Perazil, 1620-21-9, Di-Paralene, Chlorcyclizinium chloride, 14362-31-3, Chlorcyclizine chloride, Chlorcyclizine monohydrochloride, EINECS 238-335-1, NSC 169496, Chlorcyclizine (hydrochloride), 1-(p-Chlorobenzhydryl)-4-methylpiperazine monohydrochloride, 1-(p-Chloro-alpha-phenylbenzyl)-4-methylpiperazine monohydrochloride, Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-methyl-, monohydrochloride, (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine), Di-Paralene monohydrochloride, 1-((4-Chlorophenyl)(phenyl)methyl)-4-methylpiperazine hydrochloride, SMR001233306, Chlorcylizine, 1-[(4-chlorophenyl)(phenyl)methyl]-4-methylpiperazine hydrochloride, 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine;hydrochloride, SR-05000001920, Chlorcyclizine hydrochloride [USP], Prestwick_967, component of Fedrazil, Ah-289 hydrochloride, Diparalene hydrochloride, NCGC00016589-01, CAS-1620-21-9, AC1L1X2Q, Chlorocyclizine hydrochloride, DSSTox_CID_25360, DSSTox_RID_80825, DSSTox_GSID_45360, MLS002153967, MLS006010796, SCHEMBL321657, CHEMBL1889091, DTXSID7045360, CTK8F8588, MSIJLVMSKDXAQN-UHFFFAOYSA-N, HMS1570M13, Pharmakon1600-01500175, 1-(p-Chloro-alpha-phenylbenzyl)-4-methylpiperazine hydrochloride, Tox21_110511, MFCD00035329, NSC169496, NSC756678, Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-methyl-, hydrochloride, Piperazine, 1-(p-chloro-alpha-phenylbenzyl)-4-methyl-, hydrochloride, AKOS022181227, WLN: T6M DNTJ DYR&R DG &GH, API0001953, CCG-212523, HY-112067A, MCULE-3598783218, NSC-169496, NSC-756678, 4CA-0373, WLN: T6N DNTJ AYR&R DG& D &GH, LS-111212, CS-0062684, FT-0664522, FT-0697779, V1811, J-009887, SR-05000001920-3, 1-(p-Chlorobenzhydryl)-4-methylpiperazine hydrochloride, 1-(p-Chloro-.alpha.-phenylbenzyl)-4-methylpiperazine hydrochloride, 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine hydrochloride, Chlorcyclizine Hydrochloride 1.0 mg/ml in Methanol (as free base), Piperazine, 1-(p-chloro-alpha-phenylbenzyl)-4-methyl-, monohydrochloride, Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-methyl-, monohydrochloride (9CI), Piperazine, 1-(p-chloro-alpha-phenylbenzyl)-4-methyl-, monohydrochloride (8CI), Mantadil, chlorcyclizinehcl, component of Mantadil, Piperazine, hydrochloride, C18H21ClN2.xClH, UNII-NPB7A7874U, C18H21ClN2.ClH, Piperazine, monohydrochloride, Chlor Cyclizine Hydrochloride, C18H22Cl2N2, NPB7A7874U, C18-H21-Cl-N2.xCl-H, C18-H21-Cl-N2.Cl-H, CID62413, C(c1ccccc1)(c2ccc(Cl)cc2)N3CCN(C)CC3, Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-methyl-, hydrochloride, 894-56-4, Piperazine, 1-(p-chloro-.alpha.-phenylbenzyl)-4-methyl-, hydrochloride, Piperazine, 1-(p-chloro-.alpha.-phenylbenzyl)-4-methyl-, monohydrochloride, Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-methyl-, monohydrochloride,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited